Individual plans may vary
Jual micardis.80mg.mikardis.
If you notice other effects not listed above, contact your doctor or pharmacist.Call your doctor for medical advice about side effects.
Properly discard this product when it is expired or no longer needed.
Upper respiratory tract infection (7%) Back pain (3%) Sinusitis (3%) Diarrhea (3%) Cough (1.6%) Influenza-like symptoms (≥1%) Dyspepsia (≥1%) Myalgia (≥1%) Urinary tract infection (≥1%) Abdominal pain ≥1%) Headache (≥1%) Dizziness (≥1%) Pain (≥1%) Fatigue (≥1%) Coughing (≥1%) Hypertension (≥1%) Chest pain (≥1%) Nausea (≥1%) Peripheral edema (≥1%) Pharyngitis (1%) https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9yZWZlcmVuY2UubWVkc2NhcGUuY29tL2RydWcvbWljYXJkaXMtdGVsbWlzYXJ0YW4tMzQyMzIy
and formulary information changes. All material on this website is protected by copyright, Copyright © 1994-2020 by WebMD LLC.
informational and educational purposes only.
Cari produk Obat Sakit Kepala & Demam lainnya di Tokopedia. provider for the most current information.The recipient will receive more details and instructions to access this offer.By clicking send, you acknowledge that you have permission to email the recipient with this information.The recipient will receive more details and instructions to access this offer.By clicking send, you acknowledge that you have permission to email the recipient with this information.
This website also contains material copyrighted by 3rd parties. Many people using this medication do not have serious side effects.Tell your doctor right away if you have any serious side effects, including: This is not a complete list of possible side effects.
In people with PKU, the body cannot process an amino acid … 1928048-overview
If it is near the time of the next dose, skip the missed dose.
Cari produk Obat Lainnya lainnya di Tokopedia. Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.
Diseases & Conditions
Take your next dose at the regular time. Diseases & Conditions
Your list will be saved and can be edited at any time.The above information is provided for general
2002
Jual beli online aman dan nyaman hanya di Tokopedia. dengan harga Rp135.000 dari toko online Newqaiz, Jakarta Timur.
To help you remember, take it at the same time each day. 2002
Keep taking this medication even if you feel well.
Some people have low levels of L-Tyrosine in their bodies because of a hereditary condition called phenylketonuria (PKU).
Prevention of CV morbidity & mortality in patients ≥55 yr at high risk of CV disease. Commonly reported side effects of rosuvastatin include: myalgia.
Most people with Tell your doctor if your condition does not improve or if it worsens (such as your Remember that your doctor has prescribed this medication because he or she has judged that the benefit to you is greater than the risk of side effects.
This drug can cause serious (possibly fatal) harm to an unborn baby if used during Read the Patient Information Leaflet if available from your The dosage is based on your medical condition and response to treatment.Use this medication regularly to get the most benefit from it.
40 mg/day PO initially; titrated to 20-80 mg/day PO, depending on response; patients with volume depletion should receive the lower dosage initially, under close supervisionMost of the antihypertensive effect is apparent within 2 weeks and maximal reduction is generally attained after 4 weeksWhen additional blood pressure reduction is required after the 80-mg dose, a diuretic may be addedIndicated for cardiovascular (CV) risk reduction in patients unable to take ACE inhibitorsUnknown whether doses lower than 80 mg are effective in reducing the risk of cardiovascular morbidity and mortalityRenal impairment: No dosage adjustment necessary; hemodialysis (HD) patients at risk for orthostatic hypotensionUse of telmisartan with an ACE inhibitor is not recommendedAutonomic nervous system: Impotence, increased sweating, flushingCardiovascular: Palpitations, dependent edema, angina pectoris, tachycardia, leg edema, abnormal ECGCentral nervous system: Insomnia, somnolence, migraine, vertigo, paresthesia, involuntary muscle contractions, hypoesthesiaGastrointestinal: Flatulence, constipation, gastritis, vomiting, dry mouth, hemorrhoids, gastroenteritis, enteritis, gastroesophageal reflux, toothache, nonspecific gastrointestinal disordersMetabolic: Gout, hypercholesterolemia, diabetes mellitusResistance mechanism: Infection, fungal infection, abscess, otitis mediaRespiratory: Asthma, bronchitis, rhinitis, dyspnea, epistaxisSkin: Dermatitis, rash, eczema, pruritus; Urinary: micturition frequency, cystitis; Special senses: Abnormal vision, conjunctivitis, tinnitus, earacheMost frequent spontaneously reported events include: headache, dizziness, asthenia, coughing, nausea, fatigue, weakness, edema, face edema, lower limb edema, angioneurotic edema, urticaria, hypersensitivity, sweating increased, erythema, chest pain, atrial fibrillation, congestive heart failure, myocardial infarction, blood pressure increased, hypertension aggravated, hypotension (including postural hypotension), hyperkalemia, syncope, dyspepsia, diarrhea, pain, urinary tract infection, erectile dysfunction, back pain, abdominal pain, muscle cramps (including leg cramps), myalgia, bradycardia, eosinophilia, thrombocytopenia, uric acid increased, abnormal hepatic function/liver disorder, renal impairment including acute renal failure, anemia, increased CPK, anaphylactic reaction, tendon pain (including tendonitis, tenosynovitis), drug eruption (toxic skin eruption mostly reported as toxicoderma, rash, and urticaria), hypoglycemia (in diabetic patients), and angioedema (with fatal outcome)Hypersensitivity to telmisartan or any other component of this product Coadministration with aliskiren in patients with diabetesUse of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and deathHyperkalemia may occur in patients on ARBs, particularly in patients with advanced renal impairment, heart failure, on renal replacement therapy, or on potassium supplements, potassium-sparing diuretics, potassium-containing salt substitutes or other drugs that increase potassium levelAs the majority of telmisartan is eliminated by biliary excretion, patients with biliary obstructive disorders or hepatic insufficiency can be expected to have reduce clearancePregnancy (2nd and 3rd trimesters); significant risk of fetal or neonatal morbidity and mortality (see Black Box Warnings)Dual blockade of the renin-angiotensin system with angiotensin-receptor blockers (ARBs), angiotensin-converting enzyme (ACE) inhibitors, or aliskiren is associated with increased risk of hypotension, hyperkalemia, and altered renal function (including acute renal failure) in comparison with monotherapyMost patients receiving the combination of two RAS inhibitors do not obtain any additional benefit compared to monotherapy; avoid combined use of RAS inhibitors; closely monitor blood pressure, renal function and electrolytes in patients on benazepril and other agents that affect the RASMay cause fetal harm when administered to a pregnant womanUse of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and deathMost epidemiologic studies examining fetal abnormalities after exposure to antihypertensive use in the first trimester have not distinguished drugs affecting the renin-angiotensin system from other antihypertensive agentsWhen pregnancy is detected, discontinue as soon as possibleThere is no information regarding the presence of telmisartan in human milk, the effects on the breastfed infant, or the effects on milk productionAdvise a nursing woman not to breastfeed during treatmentA: Generally acceptable.